{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:33:48Z","timestamp":1759937628158,"version":"3.41.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,22]]},"DOI":"10.7759\/cureus.84618","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:01:48Z","timestamp":1747926108000},"source":"Crossref","is-referenced-by-count":1,"title":["The Treatment of Acute Cutaneous Leishmaniasis With Oral Zinc Bisglycinate and Oral Hydroxychloroquine Sulfate"],"prefix":"10.7759","author":[{"given":"Adil A","family":"Noaimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.30699\/ijp.2017.24869","article-title":"Possible interrelationship of inflammatory cells in dry type cutaneous leishmaniasis","volume":"12","author":"Taheri E","year":"2017","unstructured":"Taheri E, Dabiri S, Shamsi Meymandi M, Saedi E. Possible interrelationship of inflammatory cells in dry type cutaneous leishmaniasis. Iran J Pathol. 2017, 12:119-27.","journal-title":"Iran J Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments","volume":"23","author":"de Vries HJ","year":"2022","unstructured":"de Vries HJ, Schallig HD. Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. Am J Clin Dermatol. 2022, 23:823-40. 10.1007\/s40257-022-00726-8","journal-title":"Am J Clin Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.55519\/JAMC-04-11135","article-title":"Comparison of efficacy of miltefosine versus meglumine antimonate in the treatment of cutaneous leishmaniasis","volume":"34","author":"Mohammad N","year":"2022","unstructured":"Mohammad N, Sagheer F, Paracha MM, Khan AQ, Naseem S, Wasim M. Comparison of efficacy of miltefosine versus meglumine antimonate in the treatment of cutaneous leishmaniasis. J Ayub Med Coll Abbottabad. 2022, 34:849-53. 10.55519\/JAMC-04-11135","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011029","article-title":"Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: a collaborative retrospective study","volume":"17","author":"Castro MD","year":"2023","unstructured":"Castro MD, Rode J, Machado PR, et al.. Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: a collaborative retrospective study. PLoS Negl Trop Dis. 2023, 17:e0011029. 10.1371\/journal.pntd.0011029","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4236\/jcdsa.2016.63014","article-title":"Treatment of acute cutaneous leishmaniasis by oral zinc sulfate and oral ketoconazole singly and in combination","volume":"6","author":"Sharquie KE","year":"2016","unstructured":"Sharquie KE, Noaimi AA, Al-Salam WS. Treatment of acute cutaneous leishmaniasis by oral zinc sulfate and oral ketoconazole singly and in combination. J Cosmet Dermatol Sci. 2016, 6:105-15. 10.4236\/jcdsa.2016.63014","journal-title":"J Cosmet Dermatol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4236\/jcdsa.2017.73024","article-title":"Topical therapy of acute cutaneous leishmaniasis using zinc sulphate solution 25% versus podophyllin solution 25%","volume":"7","author":"Sharquie KE","year":"2017","unstructured":"Sharquie KE, Noaimi AA, Sharara ZAA, Saleh BA, Al-Salam WS. Topical therapy of acute cutaneous leishmaniasis using zinc sulphate solution 25% versus podophyllin solution 25%. J Cosmet Dermatol Sci. 2017, 7:258-74. 10.4236\/jcdsa.2017.73024","journal-title":"J Cosmet Dermatol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2019.05.403","article-title":"Comparing the efficacy of oral chloroquine versus oral tetracycline in the treatment of cutaneous leishmaniasis","volume":"29","author":"Malik F","year":"2019","unstructured":"Malik F, Hanif MM, Mustafa G. Comparing the efficacy of oral chloroquine versus oral tetracycline in the treatment of cutaneous leishmaniasis. J Coll Physicians Surg Pak. 2019, 29:403-5. 10.29271\/jcpsp.2019.05.403","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.51253\/PAFMJ.V71I1.3187","article-title":"Comparison of oral chloroquine with systemic meglumine antimoniate in treatment of cutaneous leishmaniasis","volume":"24","author":"Farooq M","year":"2021","unstructured":"Farooq M, Farooq MS, Bari AU, Malik T. Comparison of oral chloroquine with systemic meglumine antimoniate in treatment of cutaneous leishmaniasis. Pak Armed Forces Med J. 2021, 24:139-44. 10.51253\/PAFMJ.V71I1.3187","journal-title":"Pak Armed Forces Med J"},{"key":"ref9","article-title":"Intralesional versus oral chloroquine in cutaneous leishmaniasis: comparison of outcome, duration of treatment and total dose of drug","volume":"26","author":"Hanif MM","year":"2016","unstructured":"Hanif MM, Akram K, Mustafa G. Intralesional versus oral chloroquine in cutaneous leishmaniasis: comparison of outcome, duration of treatment and total dose of drug. J Coll Physicians Surg Pak. 2016, 26:260-2.","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref10","article-title":"Treatment of Skin Disease: Comprehensive Therapeutic Strategies, Sixth Edition","author":"Lebwohl M","year":"2022","unstructured":"Lebwohl M, Heymann WR, Coulson I, Murrell DF. Treatment of Skin Disease: Comprehensive Therapeutic Strategies, Sixth Edition. Elsevier, Amsterdam, the Netherlands; 2022."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the national center for biotechnology information","volume":"50","author":"Sayers EW","year":"2022","unstructured":"Sayers EW, Bolton EE, Brister JR, et al.. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2022, 50:D20-6. 10.1093\/nar\/gkab1112","journal-title":"Nucleic Acids Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.23880\/vij-16000233","article-title":"A holistic review on chloroquine\/hydroxychloroquine: the anti-parasitic therapeutics","volume":"28","author":"Mohamed AA","year":"2020","unstructured":"Mohamed AA. A holistic review on chloroquine\/hydroxychloroquine: the anti-parasitic therapeutics. Virol Immunol J. 2020, 28:1-12. 10.23880\/vij-16000233","journal-title":"Virol Immunol J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_280_20","article-title":"Hydroxychloroquine in dermatology and beyond: recent update","volume":"11","author":"Sardana K","year":"2020","unstructured":"Sardana K, Sinha S, Sachdeva S. Hydroxychloroquine in dermatology and beyond: recent update. Indian Dermatol Online J. 2020, 11:453-64. 10.4103\/idoj.IDOJ_280_20","journal-title":"Indian Dermatol Online J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249628","article-title":"Safety and efficacy of allylamines in the treatment of cutaneous and mucocutaneous leishmaniasis: a systematic review","volume":"16","author":"Bezemer JM","year":"2021","unstructured":"Bezemer JM, van der Ende J, Limpens J, de Vries HJ, Schallig HD. Safety and efficacy of allylamines in the treatment of cutaneous and mucocutaneous leishmaniasis: a systematic review. PLoS One. 2021, 16:e0249628. 10.1371\/journal.pone.0249628","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/nu15122813","article-title":"Comparison of the potential relative bioaccessibility of zinc supplements-in vitro studies","volume":"15","author":"O\u015bko J","year":"2023","unstructured":"O\u015bko J, Pierlejewska W, Grembecka M. Comparison of the potential relative bioaccessibility of zinc supplements-in vitro studies. Nutrients. 2023, 15:8-9. 10.3390\/nu15122813","journal-title":"Nutrients"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0396.2005.00583.x","article-title":"Bioavailability of zinc glycinate in comparison with zinc sulphate in the presence of dietary phytate in an animal model with Zn labelled rats","volume":"90","author":"Schlegel P","year":"2006","unstructured":"Schlegel P, Windisch W. Bioavailability of zinc glycinate in comparison with zinc sulphate in the presence of dietary phytate in an animal model with Zn labelled rats. J Anim Physiol Anim Nutr (Berl). 2006, 90:216-22. 10.1111\/j.1439-0396.2005.00583.x","journal-title":"J Anim Physiol Anim Nutr (Berl)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw662","article-title":"Fluconazole in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis: a randomized controlled trial","volume":"64","author":"Prates FV","year":"2017","unstructured":"Prates FV, Dourado ME, Silva SC, et al.. Fluconazole in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis: a randomized controlled trial. Clin Infect Dis. 2017, 64:67-71. 10.1093\/cid\/ciw662","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.04.014","article-title":"Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous Leishmania major infection: a randomized clinical trial","volume":"64","author":"Emad M","year":"2011","unstructured":"Emad M, Hayati F, Fallahzadeh MK, Namazi MR. Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous Leishmania major infection: a randomized clinical trial. J Am Acad Dermatol. 2011, 64:606-8. 10.1016\/j.jaad.2010.04.014","journal-title":"J Am Acad Dermatol"},{"key":"ref19","article-title":"Rifampicin for treatment of cutaneous leishmaniasis in Al-Baha region, Saudi Arabia","volume":"24","author":"AlSohaimi AA","year":"2020","unstructured":"AlSohaimi AA. Rifampicin for treatment of cutaneous leishmaniasis in Al-Baha region, Saudi Arabia. Med Sci. 2020, 24:2560-4.","journal-title":"Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/agronomy12020287","article-title":"Comparison of oral dapsone with intramuscular meglumine antimoniate in cutaneous leishmaniasis","volume":"34","author":"Ahmed N","year":"2022","unstructured":"Ahmed N, Malik S, Tahir M. Comparison of oral dapsone with intramuscular meglumine antimoniate in cutaneous leishmaniasis. J Ayub Med Coll Abbottabad. 2022, 34:15-7. 10.3390\/agronomy12020287","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.04010.x","article-title":"Tropical medicine rounds: treatment of old world cutaneous leishmaniasis with dapsone, itraconazole, cryotherapy, and imiquimod, alone and in combination","volume":"48","author":"Al-Mutairi N","year":"2009","unstructured":"Al-Mutairi N, Alshiltawy M, El Khalawany M, et al.. Tropical medicine rounds: treatment of old world cutaneous leishmaniasis with dapsone, itraconazole, cryotherapy, and imiquimod, alone and in combination. Int J Dermatol. 2009, 48:862-9. 10.1111\/j.1365-4632.2008.04010.x","journal-title":"Int J Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.22038\/rcm.2019.42632.1287","article-title":"Systemic treatments of leishmaniasis: a narrative review","volume":"4","author":"Taheri AR","year":"2019","unstructured":"Taheri AR, Sabouri Rad S, Molkara S. Systemic treatments of leishmaniasis: a narrative review. Rev Clin Med. 2019, 4:24-5. 10.22038\/rcm.2019.42632.1287","journal-title":"Rev Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/347813-the-treatment-of-acute-cutaneous-leishmaniasis-with-oral-zinc-bisglycinate-and-oral-hydroxychloroquine-sulfate","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:01:50Z","timestamp":1747926110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/347813-the-treatment-of-acute-cutaneous-leishmaniasis-with-oral-zinc-bisglycinate-and-oral-hydroxychloroquine-sulfate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.84618","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}